financetom
Business
financetom
/
Business
/
Evolv Technologies Holdings Insider Sold Shares Worth $2,952,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evolv Technologies Holdings Insider Sold Shares Worth $2,952,000, According to a Recent SEC Filing
Oct 28, 2025 1:40 PM

04:14 PM EDT, 10/28/2025 (MT Newswires) -- Anil Chitkara, Founder & Chief Growth Officer, on October 24, 2025, sold 360,000 shares in Evolv Technologies Holdings ( EVLV ) for $2,952,000. Following the Form 4 filing with the SEC, Chitkara has control over a total of 1,275,100 Class A common shares of the company, with 1,275,100 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1805385/000187090025000005/xslF345X05/wk-form4_1761681825.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: Tech: Q1 Fy 26 Sales Performance Disappoint, Completes The Exosome Divestiture
Research Alert: Tech: Q1 Fy 26 Sales Performance Disappoint, Completes The Exosome Divestiture
Nov 5, 2025
07:45 AM EST, 11/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Bio-Techne ( TECH ) reported Q1 FY 26 (Jun.) adjusted EPS of $0.42 (flat Y/Y), in line with consensus, while revenue declined 1% Y/Y to $286.6M, below consensus. The company...
Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs
Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs
Nov 5, 2025
Novo Nordisk A/S ( NVO ) on Wednesday reported third-quarter 2025 sales of roughly $11.75 billion (74.98 billion Danish kroner), slightly below the consensus of $11.88 billion. Sales increased by 5% in Danish kroner and 11% at constant currency. GLP-1 diabetes sales increased by 11% to 36.74 billion Danish kroner, and Obesity care sales increased by 18% to 21.11 billion...
Performance Food Fiscal Q1 Adjusted Earnings, Sales Rise; Updates Fiscal 2026 Revenue Guidance
Performance Food Fiscal Q1 Adjusted Earnings, Sales Rise; Updates Fiscal 2026 Revenue Guidance
Nov 5, 2025
07:44 AM EST, 11/05/2025 (MT Newswires) -- Performance Food Group ( PFGC ) reported fiscal Q1 adjusted earnings Wednesday of $1.18 per diluted share, up from $1.16 a year earlier. Analysts polled by FactSet expected $1.21. Net sales for the quarter ended Sept. 27 were $17.08 billion, compared with $15.42 billion a year earlier. Analysts surveyed by FactSet expected $16.88...
Charles River Laboratories Fiscal Q3 Non-GAAP Earnings, Revenue Drop; Fiscal 2025 Guidance Updated
Charles River Laboratories Fiscal Q3 Non-GAAP Earnings, Revenue Drop; Fiscal 2025 Guidance Updated
Nov 5, 2025
07:44 AM EST, 11/05/2025 (MT Newswires) -- Charles River Laboratories International ( CRL ) reported fiscal Q3 non-GAAP earnings Wednesday of $2.43 per diluted share, down from $2.59 a year earlier. Analysts polled by FactSet expected $2.34. Total revenue for the quarter ended Sept. 27 was $1 billion, down from $1.01 billion a year earlier. Analysts surveyed by FactSet expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved